These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3975177)

  • 61. Prostatic tissue and secretion concentrations of rosamicin and erythromycin. Experimental studies in the dog.
    Baumueller A; Kjaer TB; Madsen PO
    Invest Urol; 1977 Sep; 15(2):158-60. PubMed ID: 903212
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv.
    Piddock LJ; Ricci V
    J Antimicrob Chemother; 2001 Dec; 48(6):787-91. PubMed ID: 11733462
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multiple-dose ciprofloxacin kinetics in normal subjects.
    Aronoff GE; Kenner CH; Sloan RS; Pottratz ST
    Clin Pharmacol Ther; 1984 Sep; 36(3):384-8. PubMed ID: 6467798
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs.
    Bidgood TL; Papich MG
    J Vet Pharmacol Ther; 2005 Aug; 28(4):329-41. PubMed ID: 16050812
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical pharmacokinetics and pharmacodynamic target attainment of pazufloxacin in prostate tissue: Dosing considerations for prostatitis.
    Nakamura K; Ikawa K; Nishikawa G; Kobayashi I; Narushima M; Muramatsu H; Morinaga S; Kajikawa K; Kato Y; Watanabe M; Zennami K; Kanao K; Morikawa N; Sumitomo M
    J Infect Chemother; 2017 Dec; 23(12):809-813. PubMed ID: 28923301
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Penetration of ciprofloxacin into kidney, fat, muscle and skin tissue.
    Daschner FD; Westenfelder M; Dalhoff A
    Eur J Clin Microbiol; 1986 Apr; 5(2):212-3. PubMed ID: 2941285
    [No Abstract]   [Full Text] [Related]  

  • 67. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In-vitro susceptibility of staphylococci to fleroxacin in comparison with six other quinolones.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():35-41. PubMed ID: 3144547
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Application of muscle microdialysis to evaluate the concentrations of the fluoroquinolones pazufloxacin and ofloxacin in the tissue interstitial fluids of rats.
    Araki H; Ogake N; Minami S; Watanabe Y; Narita H; Tamai I; Tsuji A
    J Pharm Pharmacol; 1997 Nov; 49(11):1141-4. PubMed ID: 9401953
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1H-pyrrol-1-yl)-quinoline-3-carb oxylic acid, a new fluorinated compounds of oxacin family with high broad-spectrum antibacterial activities.
    Stefancich G; Artico M; Corelli F; Massa S; Panico S; Simonetti N
    Farmaco Sci; 1985 Apr; 40(4):237-48. PubMed ID: 3926533
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of ofloxacin and norfloxacin concentration in prostatic tissues in patients undergoing transurethral resection of the prostate.
    Chen J; Chen RR; Huang HS
    J Formos Med Assoc; 2001 Aug; 100(8):548-52. PubMed ID: 11678006
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae.
    Hedlin P; Blondeau JM
    Eye Contact Lens; 2007 May; 33(3):161-4. PubMed ID: 17502752
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves.
    Davis JL; Foster DM; Papich MG
    J Vet Pharmacol Ther; 2007 Dec; 30(6):564-71. PubMed ID: 17991225
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determination of plasma and skin concentrations of orbifloxacin in dogs with clinically normal skin and dogs with pyoderma.
    Kay-Mugford PA; Weingarten AJ; Ngoh M; Zolynas R; White A; Katz T; Simmons R; Varma KJ
    Vet Ther; 2002; 3(4):402-8. PubMed ID: 12584677
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Secretion of the antibacterial substance trimethoprim in the prostatic fluid of dogs.
    Reeves DS; Ghilchik M
    Br J Urol; 1970 Feb; 42(1):66-72. PubMed ID: 5435704
    [No Abstract]   [Full Text] [Related]  

  • 76. Penetration of ciprofloxacin into female pelvic tissues.
    Segev S; Rubinstein E; Shick J; Rabinovitch O; Dolitsky M
    Eur J Clin Microbiol; 1986 Apr; 5(2):207-9. PubMed ID: 2941283
    [No Abstract]   [Full Text] [Related]  

  • 77. [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci].
    Hidalgo M; Reyes J; Cárdenas AM; Díaz L; Rincón S; Vanegas N; Díaz PL; Castañeda E; Arias CA
    Biomedica; 2008 Jun; 28(2):284-94. PubMed ID: 18719726
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog.
    Cester CC; Toutain PL
    J Pharm Sci; 1997 Oct; 86(10):1148-55. PubMed ID: 9344173
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro activity of amifloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Freeman S; Wormuth J; Cornett J
    Eur J Clin Microbiol; 1985 Oct; 4(5):515-6. PubMed ID: 4065142
    [No Abstract]   [Full Text] [Related]  

  • 80. Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids.
    Gasser TC; Graversen PH; Madsen PO
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1010-3. PubMed ID: 3116916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.